Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer
Folprecht, Gunnar, Tabernero, Josep, Köhne, Claus-Henning, Zacharchuk, Charles, Paz-Ares, Luis, Rojo, Federico, Quinn, Susan, Casado, Esther, Salazar, Ramon, Abbas, Richat, Lejeune, Chantal, Marimón, Irene, Andreu, Jordi, Ubbelohde, Ulrike, Cortes-Funes, Hernan, Baselga, Jose
Published in Clinical cancer research (01.01.2008)
Published in Clinical cancer research (01.01.2008)
Get full text
Journal Article
A Phase III study at high risk for recurrence
Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen
Published in Journal for immunotherapy of cancer (04.11.2015)
Published in Journal for immunotherapy of cancer (04.11.2015)
Get full text
Journal Article
A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence
Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen
Published in Journal for immunotherapy of cancer (04.11.2015)
Published in Journal for immunotherapy of cancer (04.11.2015)
Get full text
Journal Article
Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-LineTreatment of Patients with Metastatic Colorectal Cancer
FOLPRECHT, Gunnar, TABERNERO, Josep, LEJEUNE, Chantal, MARIMON, Irene, ANDREU, Jordi, UBBELOHDE, Ulrike, CORTES-FUNES, Hernan, BASELGA, Jose, KÖHNE, Claus-Henning, ZACHARCHUK, Charles, PAZ-ARES, Luis, ROJO, Federico, QUINN, Susan, CASADO, Esther, SALAZAR, Ramon, ABBAS, Richat
Published in Clinical cancer research (2008)
Get full text
Published in Clinical cancer research (2008)
Journal Article
Preliminary Report of a Phase 1 Study of CMC-544, an Antibody-Targeted Chemotherapy Agent, in Patients with B-Cell Non-Hodgkin's Lymphoma (NHL)
Advani, Anjali, Giné, Eva, Gisselbrecht, Christian, Rohatiner, Ama, Rosen, Steven, Smith, Mitchell, Boni, Joseph, Lejeune, Chantal, Patel, Hemant
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Antibody‐targeted chemotherapy of relapsed aml
Mineur, Philippe, Lejeune, Chantal, Hennaux, Vincent, Eten, Catharine
Published in British journal of haematology (01.04.2003)
Published in British journal of haematology (01.04.2003)
Get full text
Journal Article
Antibody-targeted chemotherapy of relapsed AML
Mineur, Philippe, Lejeune, Chantal, Hennaux, Vincent, Eten, Catharine
Published in British journal of haematology (01.04.2003)
Get full text
Published in British journal of haematology (01.04.2003)
Report